Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections

ClinicalTrials.gov ID: NCT00413218

Public ClinicalTrials.gov record NCT00413218. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to compare the safety and efficacy of isavuconazole versus caspofungin followed by voriconazole in the treatment of candidemia and other invasive Candida infections.

Study identification

NCT ID
NCT00413218
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
450 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 8, 2007 (Actual)
Primary completion
Mar 3, 2015 (Actual)
Completion
Mar 3, 2015 (Actual)
Last update posted
Dec 10, 2024

2007 – 2015

United States locations

U.S. sites
18
U.S. states
15
U.S. cities
18
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294-0006 —
Somero Research Corporation Palm Desert California 92211 —
University of California Davis Health System Sacramento California 95817 —
University of California at San Francisco San Francisco California 94143 —
Idaho Falls Infectious Diseases PLLC Idaho Falls Idaho 83404 —
Loyola University Hospital Maywood Illinois 60153 —
Springfield Clinic LLP Springfield Illinois 62701 —
Infectious Disease of Indiana Indianapolis Indiana 46280 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
University of Maryland School of Medicine Baltimore Maryland 21201 —
UMASS Memorial Medical Center Worcester Massachusetts 01655 —
Henry Ford Hospital Detroit Michigan 48202 —
Mercury Street Medical Group Butte Montana 59701 —
Jersey Shore University Medical Center Neptune City New Jersey 07753 —
New York Presbyterian Hospital New York New York 10065 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
Regional Infection Diseases Infusion Center Inc. Lima Ohio 45801 —
Temple University Health Sciences Philadelphia Pennsylvania 19140 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00413218, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00413218 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →